Creative Medical Technology Holdings, Inc. (CELZ)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
As of 12:06PM EDT. Market open.
Currency in USD
Valuation Measures4
| Market Cap (intraday) | 5.95M |
| Enterprise Value | -4.04M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 685.83 |
| Price/Book (mrq) | 0.58 |
| Enterprise Value/Revenue | -448.69 |
| Enterprise Value/EBITDA | 0.73 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 5.04 |
| 52-Week Change 3 | -34.45% |
| S&P500 52-Week Change 3 | 24.19% |
| 52 Week High 3 | 10.2812 |
| 52 Week Low 3 | 3.9300 |
| 50-Day Moving Average 3 | 5.0374 |
| 200-Day Moving Average 3 | 4.8168 |
Share Statistics
| Avg Vol (3 month) 3 | 211.32k |
| Avg Vol (10 day) 3 | 15.19k |
| Shares Outstanding 5 | 1.36M |
| Implied Shares Outstanding 6 | 1.48M |
| Float 8 | 1.32M |
| % Held by Insiders 1 | 2.71% |
| % Held by Institutions 1 | 2.66% |
| Shares Short (Apr 15, 2024) 4 | 23.24k |
| Short Ratio (Apr 15, 2024) 4 | 1.05 |
| Short % of Float (Apr 15, 2024) 4 | 1.76% |
| Short % of Shares Outstanding (Apr 15, 2024) 4 | 1.71% |
| Shares Short (prior month Mar 15, 2024) 4 | 41.47k |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | 0.00 |
| Trailing Annual Dividend Yield 3 | 0.00% |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | N/A |
| Ex-Dividend Date 4 | N/A |
| Last Split Factor 2 | 1:10 |
| Last Split Date 3 | Jun 12, 2023 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | Dec 31, 2023 |
| Most Recent Quarter (mrq) | Dec 31, 2023 |
Profitability
| Profit Margin | 0.00% |
| Operating Margin (ttm) | -59,061.30% |
Management Effectiveness
| Return on Assets (ttm) | -23.49% |
| Return on Equity (ttm) | -40.34% |
Income Statement
| Revenue (ttm) | 9k |
| Revenue Per Share (ttm) | 0.01 |
| Quarterly Revenue Growth (yoy) | -83.90% |
| Gross Profit (ttm) | N/A |
| EBITDA | -5.53M |
| Net Income Avi to Common (ttm) | -5.29M |
| Diluted EPS (ttm) | -3.7600 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 9.99M |
| Total Cash Per Share (mrq) | 7.36 |
| Total Debt (mrq) | 14.19k |
| Total Debt/Equity (mrq) | 0.14% |
| Current Ratio (mrq) | 27.66 |
| Book Value Per Share (mrq) | 7.53 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -8.03M |
| Levered Free Cash Flow (ttm) | -6.37M |
© 2024 Yahoo. All rights reserved.